ArticleFrontiers in immunology2025

Complete remission of recurrent human papillomavirus-associated cervical cancer managed with camrelizumab and nanoparticle albumin-bound paclitaxel as second-line treatment: a case report.

Liping Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.